1. Home
  2. NAD vs ATRC Comparison

NAD vs ATRC Comparison

Compare NAD & ATRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nuveen Quality Municipal Income Fund

NAD

Nuveen Quality Municipal Income Fund

HOLD

Current Price

$10.37

Market Cap

2.4B

Sector

Finance

ML Signal

HOLD

Logo AtriCure Inc.

ATRC

AtriCure Inc.

HOLD

Current Price

$57.87

Market Cap

2.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NAD
ATRC
Founded
1999
2000
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.4B
2.5B
IPO Year
N/A
2005

Fundamental Metrics

Financial Performance
Metric
NAD
ATRC
Price
$10.37
$57.87
Analyst Decision
Buy
Analyst Count
0
10
Target Price
N/A
★ $55.78
AVG Volume (30 Days)
★ 2.2M
869.9K
Earning Date
01-01-0001
11-03-2026
Dividend Yield
★ 4.35%
N/A
EPS Growth
N/A
★ 74.74
EPS
N/A
★ 0.18
Revenue
N/A
★ $201,630,000.00
Revenue This Year
N/A
$13.42
Revenue Next Year
N/A
$12.12
P/E Ratio
★ N/A
$320.69
Revenue Growth
N/A
★ 15.40
52 Week Low
$9.66
$25.36
52 Week High
$12.31
$61.70

Technical Indicators

Market Signals
Indicator
NAD
ATRC
Relative Strength Index (RSI) 48.43 57.13
Support Level $9.75 $26.95
Resistance Level $11.92 $61.70
Average True Range (ATR) 0.19 2.13
MACD 0.08 -0.15
Stochastic Oscillator 82.17 77.20

Price Performance

Historical Comparison
NAD
ATRC

About NAD Nuveen Quality Municipal Income Fund

Nuveen Quality Municipal Income Fund is a diversified, closed-end management investment company. Its investment objective is to provide current income exempted from regular federal income tax by investing in tax-exempt municipal securities that the Fund's investment adviser believes are underrated or undervalued or that represent municipal market sectors that are undervalued.

About ATRC AtriCure Inc.

AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation, Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.

Share on Social Networks: